Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
The long terminal repeat (LTR) is reported to be one of the most variable portions of the equine infectious anemia virus (EIAV) genome. To date, however, no information is available on the effects of observed sequence variations on viral replication properties, despite a widespread assumption of the biological importance of EIAV LTR variation. EIAV LTR sequence variability is confined mostly to a small portion of the enhancer within the U3 segment of the LTR. Analysis of published EIAV LTR sequences revealed six different types of LTR based on the pattern of putative transcription factor motifs within the variable region of the enhancer. To test directly the significance of LTR variation, the in vitro and in vivo replication properties of two variant LTR species were investigated using two isogenic viruses, EIAV(19-2) and EIAV(19-2-6A), differing only within the enhancer region. The results of these studies demonstrated that the two variants replicated with similar kinetics and to equal levels in cultured equine fibroblasts or in equine macrophage, the natural target cell of EIAV, even after prolonged serial passage in the latter cell type. Furthermore, EIAV(19-2) and EIAV(19-2-6A) variants demonstrated similar replication levels in experimentally infected ponies. However, ponies infected with EIAV(19-2-6A) exhibited a rapid switch in the prevalent LTR type, such that by 112 days postinfection, no original-LTR-type viruses were evident. This specific and rapid shift in LTR quasispecies indicates an in vivo selection that is not reflected in simple in vitro replication rates, suggesting undefined selection pressures in vivo that drive LTR variation during persistent EIAV infection.
Lichtenstein
D L
DL
Department of Molecular Genetics and Biochemistry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.
Craigo
J K
JK
Leroux
C
C
Rushlow
K E
KE
Cook
R F
RF
Cook
S J
SJ
Issel
C J
CJ
Montelaro
R C
RC
D000818:Animals; D001483:Base Sequence; D002460:Cell Line; D004742:Enhancer Elements, Genetic / Q000235:genetics; D004859:Equine Infectious Anemia / Q000097:blood / Q000821:virology; D005347:Fibroblasts / Q000821:virology; D014644:Genetic Variation / Q000235:genetics* / Q000502:physiology; D006736:Horses / Q000821:virology; D004860:Infectious Anemia Virus, Equine / Q000235:genetics* / Q000254:growth & development* / Q000472:pathogenicity; D008264:Macrophages / Q000821:virology; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics; D020218:Response Elements / Q000235:genetics; D012641:Selection, Genetic; D012692:Serial Passage; D020079:Terminal Repeat Sequences / Q000235:genetics* / Q000502:physiology; D014157:Transcription Factors / Q000378:metabolism; D014766:Viremia / Q000097:blood / Q000821:virology; D014779:Virus Replication / Q000235:genetics*
D012367:RNA, Viral; D014157:Transcription Factors